Incidence of lymphedema related to various cancers Marie-Eve LetellierMarize IbrahimGeneviève Chaput Review Open access 17 September 2024 Article: 245
The Sirt1/Nrf2 pathway is a key factor for drug therapy in chemotherapy-induced cardiotoxicity: a Mini-Review Suleiman Ibrahim Shelash MohammadAsokan VasudevanAhmed Hussein Zwamel Review Article 11 September 2024 Article: 244
Lipid metabolism reprogramming in renal cell carcinomas Mustafa Khalid AbduljabbarMohammed MerzaBenien C. Gabel Review 06 September 2024 Article: 243
Turning the tide: pembrolizumab’s triumph in adjuvant RCC therapy Fouad AttiehMarc BoutrosMervat Mahrous Review 05 September 2024 Article: 242
Current diagnostic and quantitative techniques in the field of lymphedema management: a critical review Mary VargoMelissa AldrichAndrea Cheville Review Open access 05 September 2024 Article: 241
The role of IL-22 in cancer Zachary E. HunzekerLei ZhaoYujiang Fang Review 05 September 2024 Article: 240
Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology Akbar OghalaieMahmoud Eshagh HosseiniFatemeh Kazemi-Lomedasht Review 04 September 2024 Article: 239
How mitochondrial dynamics imbalance affects the progression of breast cancer:a mini review Jingwen KuangHao LiuPengcheng Xu Review Open access 01 September 2024 Article: 238
Letter to the editor: comment on “Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment” Murali Santhoshkumar Comment 30 August 2024 Article: 237
The treatment landscape of triple-negative breast cancer Yi HuChen WangQiong Yang Review Article 29 August 2024 Article: 236
Letter to the editor: comment on “Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study” Adane Desta GonemoAjay Prakash PasupullaMurali Santhoshkumar Comment 29 August 2024 Article: 235
Letter to the editor: Comment on “Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment” Ramya RajendiranMurali Santhoshkumar Comment 23 August 2024 Article: 234
The potential of lenvatinib in breast cancer therapy Yuefeng ShangTong LiuWenjing Wang Review 22 August 2024 Article: 233
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α Yasmin M. AttiaHamada Ahmed MokhlisMarwa Sharaky Original Paper Open access 21 August 2024 Article: 232
Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer Makan CheraghpourNayeralsadat FatemiLuis G. Bermúdez-Humarán Review 20 August 2024 Article: 231
A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms Ayşe Hale AlkanMine EnsoyDemet Cansaran-Duman Original Paper 19 August 2024 Article: 229
2023 ACS – LANA lymphedema summit forward momentum; future steps in lymphedema management Elizabeth CampioneDavid Doubblestein Editorial 19 August 2024 Article: 230
Moscatilin, a potential therapeutic agent for cancer treatment: insights into molecular mechanisms and clinical prospects Rita Silva-ReisVera L. M. SilvaJavad Sharifi-Rad Review Article 17 August 2024 Article: 228
Cancer/testis antigen expression and co-expression patterns in gastroesophageal adenocarcinoma Sukumar KalvapudiAkhil Goud PachimatlaSarbajit Mukherjee Original Paper Open access 14 August 2024 Article: 227
Therapeutic response and safety of radioligand therapy with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer patients Wardah AshfaqKhurram RehmanMuhammad Numair Younis Original Paper 13 August 2024 Article: 226
Letters to editor regarding the article “P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway” K. L. G. AfeezaS. BalachandranE. Dilipan Editorial 13 August 2024 Article: 225
Diverse roles of aldolase enzymes in cancer development, drug resistance and therapeutic approaches as moonlighting enzymes Fan TangQingyang Cui Review 09 August 2024 Article: 224
Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review Ehsan MehrtabarAmirreza KhalajiMehdi Soleymani-Goloujeh Review 09 August 2024 Article: 222
Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins Nawal HelmiAbdullah HamadiMisbahuddin M. Rafeeq Original Paper 09 August 2024 Article: 223
Emerging roles of the chromatin remodeler MORC2 in cancer metabolism Bibhukalyan MohapatraSuresh B. Pakala Review 08 August 2024 Article: 221
Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells Mano Chitra KarthikeyanChandhru SrinivasanAntony Joseph Velanganni Arockiam Original Article 08 August 2024 Article: 220
Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study Asim JoshiAbantika GhoshPrashant Kumar Original Paper 06 August 2024 Article: 219
Comment on “Pharmacokinetic studies, molecular docking, and molecular dynamics simulations of phytochemicals from Morus alba: a multi-receptor approach for potential therapeutic agents in colorectal cancer” YuHan WangYaLing LiJun Li Comment 05 August 2024 Article: 216
Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay Hanan ElimamSherif S. Abdel MageedAhmed S. Doghish Review 05 August 2024 Article: 218
Tetrahydroisoquinoline reduces angiogenesis by interacting myeloma cells with HUVECs mediated by extracellular vesicles Ahmad KooshariFahimeh ShahriyaryMohammad Reza Amirzargar Original Paper 05 August 2024 Article: 217
Comment on ‘Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression’ Nilina James Comment 01 August 2024 Article: 215
Targeted gene therapy for cancer: the impact of microRNA multipotentiality Nourhan A. Abou MadawiZeinab E. DarwishEnas M. Omar Review Article Open access 01 August 2024 Article: 214
Correction to: Auraptene‑induced cytotoxic effects in acute myeloid leukemia cell Lines Majid GhorbaniMohammad SoukhtanlooMohammad Hadi Sadeghian Correction 30 July 2024 Article: 213
Mining parasites for their potential as novel therapeutic agents against cancer Neha Sylvia WalterShalmoli Bhattacharyya Review Article 29 July 2024 Article: 211
Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma Jie LiuYung-Ting ChangFan Yang Original Paper 29 July 2024 Article: 212
Allicin: a promising modulator of apoptosis and survival signaling in cancer Sunaina BhukerAvneet KaurMadhu Gupta Review Article 26 July 2024 Article: 210
Current advances in cancer energy metabolism under dietary restriction: a mini review Liuxin YangYudian ShaoXingxing Yuan Review Article 26 July 2024 Article: 209
Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer Dania A. Nava-TapiaNorely Y. Román-JustoMiguel A. Mendoza-Catalán Review Article 26 July 2024 Article: 208
PARK2 suppresses the proliferation of high-grade serous ovarian carcinoma via inducing the proteasomal degradation of ZNF703 Fangfang WangYan LiPeiling Li Original Paper 23 July 2024 Article: 207
Anticancer effects of Artemisia campestris extract on acute myeloid leukemia cells: an ex vivo study Rachid KharratFatma Ben LakhalMohamed Abdelkarim Original Paper 22 July 2024 Article: 206
Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer Mahdieh Ahmadi KamalabadiHamid OstadebrahimiAmin Shiralizadeh Dezfuli Original Paper 22 July 2024 Article: 205
Therapeutic and diagnostic applications of exosomes in colorectal cancer Neda ShakerianElham Darzi-EslamSaeed Khalili Review Article 20 July 2024 Article: 203
Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells Pratiksha Somnath KumkarRatul ChakrabortyAsis Bala Original Paper 20 July 2024 Article: 204
The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy Chou-Yi HsuMustafa Nasrat AbdulrahimMohammed Shnain Ali Review 15 July 2024 Article: 202
Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations Mohamed J. SaadhMohammed Ahmed MustafaMunther Kadhim Abosaoda Review Article 13 July 2024 Article: 201
Anti-cancer potential of casein and its derivatives: novel strategies for cancer treatment Daniel Romero-TrejoItzen Aguiñiga-SanchezEdelmiro Santiago-Osorio Review Article Open access 11 July 2024 Article: 200
Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer Fatima SarwarSamreen AshhadReena Vishvakarma Review article 10 July 2024 Article: 199
Molecular docking aided machine learning for the identification of potential VEGFR inhibitors against renal cell carcinoma Vidya Sagar JerraBalajee RamachandranSrinivasadesikan Venkatesan Original Paper 09 July 2024 Article: 198
Utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in elderly patients: a retrospective cohort study Wesley H. ChouAlexis WangSudhir Isharwal Original Paper 09 July 2024 Article: 197
Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial Khlood M. KettanaSahar M. El‑HaggarDalia R. El‑Afify Original Paper Open access 08 July 2024 Article: 196